Specials

prof-sir-george-radda-chairman-biomedical-research-council-singapore-gets-biospectrum-asia-pacific-awards-2013-in-the-lifetime-achievement-award-2013-category

BSA lifetime achievement award 2013 for George Radda

  • Singapore
  • |
  • Influencers

The present chairman of Singapore's Biomedical Research Council (BMRC) Prof Sir George Radda has changed the way universities in Singapore approach the research paradigm. His pioneering efforts have elevated Singapore's research potential... Read more

volitionrx-singapore-gets-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

Affordable cancer diagnostics wins VolitionRx BioSpectrum...


  • Singapore
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Driven by the demand for affordable and simple diagnostics, VolitionRx has been focusing on diagnostic tests for cancer that... Read more

dr-deborah-rathjen-ceo-md-bionomics-australia-gets-biospectrum-asia-pacific-awards-2013-in-the-person-of-the-year-2013-category

Australia’s power woman Deborah Rathjen wins BioSpectrum...


  • Australia
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped... Read more

Market cap in APAC

Market cap in APAC touches $200 bn

  • Australia
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges... Read more

ResMed builds on partnerships for growth

ResMed builds on partnerships for growth

  • Australia
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisitions and product... Read more

The biofuel wonder

LanzaTech: The biofuel wonder

  • New Zealand
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 1 Comment

With the rising cost of fuel and the depleting reserves, the world is pinning its hopes on viable options for biofuels. While many companies... Read more

Cipla nurtures global vision for affordable drugs

Cipla nurtures global vision for affordable drugs

  • India
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market. Without missing... Read more

Aricept leads Japan pharma market

Aricept leads Japan pharma market with $1.81 bn

  • Japan
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to about 10 percent... Read more

Lipitor leads in Australia

Lipitor leads in Australia

  • Australia
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China.... Read more

China holds largest pharma revenue share in APAC

China holds largest pharma revenue share in APAC

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 1 Comment

In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest share of the market.... Read more

Novo Nordisk Insulin top pharma product in India

Novo Nordisk insulin top pharma product in India

  • India
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 1 Comment

India, which has the second largest population in the world and is among the top three nations in terms of patient pool, secured revenues... Read more

China and Australia dominate APAC pharma market

China, Australia dominate APAC pharma market

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 2011, riding on various... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X